• 1
    Shapiro S, Venet W, Strax P, Venet L, Roeser R. Ten- to fourteen-year effect of screening on breast cancer mortality. J Natl Cancer Inst 1982; 69: 34955.
  • 2
    Tabár L, Fagerberg CJG, Gad A, Baldetorp L, Holmberg LH, Gröntoft O, Ljungquist U, Lundström B, Månson JC, Eklund G, Day NE, Pettersson F. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 1985; 1: 82932.
  • 3
    Nyström L, Rutqvist L, Wall S, Lindgren A, Lindqvist M, Rydén S, Andersson I, Bjurstam N, Fagerberg G, Frisell J, Tab́r L, Larsson L-E. Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet 1993; 341: 9738.
  • 4
    Duffy SW, Tabár L, Chen HH, Holmqvist M, Yen MF, Abdsalah S, Epstein B, Frodis E, Ljungberg E, Hedborg-Melander C, Sundbom A, Tholin M, et al. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties. Cancer 2002; 95: 45869.
  • 5
    Hakama M, Pukkala E, Heikkila M, Kallio M. Effectiveness of the public health policy for breast cancer screening in Finland: population based cohort study. BMJ 1997; 314: 8647.
  • 6
    Jonsson H, Nyström L, Törnberg S, Lenner P. Service screening with mammography of women aged 50–69 years in Sweden: effects on mortality from breast cancer. J Med Screen 2001; 8: 15260.
  • 7
    Sakr WA, Haas GP, Cassin BF, Pontes JE, Crissman JD. The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J Urol 1993; 150: 37985.
  • 8
    Zahl PH, Strand BH, Maehlen J. Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study. BMJ 2004; 328: 9214.
  • 9
    Peeters PH, Verbeek AL, Straatman H, Holland R, Hendriks JH, Mravunac M, Rothengatter C, Van Dijk-Milatz A, Werre JM. Evaluation of overdiagnosis of breast cancer in screening with mammography: results of the Nijmegen programme. Int J Epidemiol 1989; 18: 2959.
  • 10
    Shapiro S, Strax P, Venet L. Periodic breast cancer screening in reducing mortality from breast cancer. JAMA 1971; 215: 177785.
  • 11
    Tabár L, Akerlund E, Gad A. Five-year experience with single-view mammography randomized controlled screening in Sweden. Recent Results Cancer Res 1984; 90: 10513.
  • 12
    Olsen AH, Jensen A, Njor SH, Villadsen E, Schwartz W, Vejborg I, Lynge E. Breast cancer incidence after the start of mammography screening in Denmark. Br J Cancer 2003; 88: 3625.
  • 13
    Olsson S, Andersson I, Karlberg I, Bjurstam N, Frodis E, Hakansson S. Implementation of service screening with mammography in Sweden: from pilot study to nationwide programme. J Med Screen 2000; 7: 148.
  • 14
    Duffy SW, Day NE, Tabar L, Chen HH, Smith TC. Markov models of breast tumor progression: some age-specific results. J Natl Cancer Inst Monogr 1997; 22: 937.
  • 15
    McCullagh P, Nelder JA. Generalized linear models, 2nd ed. London: Chapman and Hall/CRC, 1989.
  • 16
    Venables WN, Ripley BD. Modern applied statistics with S, 4th ed. New York: Springer, 2002.
  • 17
    Paci E, Warwick J, Falini P, Duffy SW. Overdiagnosis in screening: is the increase in breast cancer incidence rates a cause for concern? J Med Screen 2004; 11: 237.
  • 18
    Jonsson H, Larsson LG, Lenner P. Detection of breast cancer with mammography in the first screening round in relation to expected incidence in different age groups. Acta Oncol 2003; 42: 229.
  • 19
    Clemmesen J. Results from statistical research (Symposium). Brit J Radiol 1948; 21: 85390.